Back
Consolidated Edison 10K Form
Sell
37
ED
Consolidated Edison
Last Price:
99.80
Seasonality Move:
3.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ED/Consolidated Edison Quarterly |
2024-02-15 | 10K | ED/Consolidated Edison Annual |
2023-11-02 | 10Q | ED/Consolidated Edison Quarterly |
2023-08-03 | 10Q | ED/Consolidated Edison Quarterly |
2023-05-04 | 10Q | ED/Consolidated Edison Quarterly |
2023-02-16 | 10K | ED/Consolidated Edison Annual |
Receive ED News And Ratings
See the #1 stock for the next 7 days that we like better than ED
ED Financial Statistics
Sales & Book Value
Annual Sales: | $14.66B |
---|---|
Cash Flow: | $180M |
Price / Cash Flow: | 0 |
Annual Sales: | $62.31 |
Price / Book: | 1.6 |
Profitability
EPS (TTM): | 5.15000 |
---|---|
Net Income (TTM): | $1.78B |
Gross Margin: | $7.41B |
Return on Equity: | 8.39% |
Return on Assets: | 2.71% |
Consolidated Edison Earnings Forecast
Key Consolidated Edison Financial Ratios
- The Gross Profit Margin over the past 30 years for ED is 50.50%.
- The Selling, General & Administrative Expenses for ED have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 40.61% of Operating Income.
- The Net Earning history of ED is 17.18% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 24 years.
Consolidated Edison Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Multi-Utilities |
Sector: | Utilities |
Current Symbol: | ED |
CUSIP: | 209115 |
Website: | conedison.com |
Debt
Debt-to-Equity Ratio: | 1.21 |
---|---|
Current Ratio: | 1.04 |
Quick Ratio: | 0.82 |
Price-to-Earnings
Trailing P/E Ratio: | 13.84 |
---|---|
Forward P/E Ratio: | 17.75 |
ED Technical Analysis vs Fundamental Analysis
Sell
37
Consolidated Edison (ED)
is a Sell
Is Consolidated Edison a Buy or a Sell?
-
Consolidated Edison stock is rated a Sell
The current Consolidated Edison [ED] share price is $99.82. The Score for ED is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.